Guggenheim Capital LLC lowered its holdings in AmerisourceBergen Corp. (NYSE:ABC) by 3.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 649,931 shares of the company’s stock after selling 23,311 shares during the period. Guggenheim Capital LLC owned approximately 0.30% of AmerisourceBergen worth $59,679,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Delpha Capital Management LLC purchased a new stake in shares of AmerisourceBergen in the 4th quarter valued at about $137,000. Vantage Investment Advisors LLC purchased a new stake in shares of AmerisourceBergen in the 4th quarter valued at about $156,000. TRUE Private Wealth Advisors purchased a new stake in shares of AmerisourceBergen in the 4th quarter valued at about $203,000. Zeke Capital Advisors LLC purchased a new stake in shares of AmerisourceBergen in the 3rd quarter valued at about $210,000. Finally, IBM Retirement Fund purchased a new stake in shares of AmerisourceBergen in the 4th quarter valued at about $216,000. 67.33% of the stock is currently owned by hedge funds and other institutional investors.
AmerisourceBergen Corp. (NYSE ABC) opened at $100.60 on Wednesday. The firm has a market capitalization of $22,030.61, a PE ratio of 16.50, a P/E/G ratio of 1.50 and a beta of 1.03. The company has a current ratio of 0.95, a quick ratio of 0.50 and a debt-to-equity ratio of 1.61. AmerisourceBergen Corp. has a 1-year low of $71.90 and a 1-year high of $106.27.
The business also recently declared a quarterly dividend, which was paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th were paid a $0.38 dividend. The ex-dividend date of this dividend was Friday, February 16th. This represents a $1.52 dividend on an annualized basis and a yield of 1.51%. AmerisourceBergen’s dividend payout ratio (DPR) is currently 32.76%.
Several analysts have weighed in on ABC shares. Argus raised their price target on AmerisourceBergen from $93.96 to $115.00 and gave the company a “buy” rating in a report on Monday, March 5th. Zacks Investment Research cut AmerisourceBergen from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Goldman Sachs Group raised AmerisourceBergen from a “neutral” rating to a “buy” rating in a report on Friday, December 15th. Bank of America started coverage on AmerisourceBergen in a report on Tuesday, February 27th. They issued a “buy” rating and a $111.00 price target on the stock. Finally, Deutsche Bank started coverage on AmerisourceBergen in a report on Monday, December 4th. They issued a “buy” rating and a $97.00 price target on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $103.34.
In other AmerisourceBergen news, Director Richard W. Gochnauer sold 2,278 shares of AmerisourceBergen stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $101.13, for a total value of $230,374.14. Following the transaction, the director now directly owns 13,225 shares of the company’s stock, valued at approximately $1,337,444.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Peyton R. Howell sold 17,800 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, December 14th. The stock was sold at an average price of $89.70, for a total value of $1,596,660.00. The disclosure for this sale can be found here. Insiders sold a total of 177,609 shares of company stock worth $16,855,249 over the last ninety days. Insiders own 27.30% of the company’s stock.
WARNING: “AmerisourceBergen Corp. (ABC) Holdings Decreased by Guggenheim Capital LLC” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/03/14/amerisourcebergen-corp-abc-holdings-decreased-by-guggenheim-capital-llc.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.